Literature DB >> 19864882

Use of multidetector row CT to evaluate the need for bronchial arterial embolization in hemoptysis patients.

Hidenori Mori1, Yasushi Ohno, Yusuke Tsuge, Masanori Kawasaki, Fumitaka Ito, Junki Endo, Norihiko Funaguchi, Bu Lin Bai La, Masayuki Kanematsu, Shinya Minatoguchi.   

Abstract

BACKGROUND: Bronchial artery (BA) embolization (BAE) is recommended as a minimally invasive therapy for hemoptysis, though some patients recover after only conservative treatment.
OBJECTIVES: The purpose of our study was to assess the characteristics of BAs using multidetector row computed tomography (MDCT) and identify BAs requiring BAE without BA angiography (BAG).
METHODS: We retrospectively studied 41 patients and classified the visualized BAs into groups based on their BAE and bleeding statuses. Patients presenting with massive hemoptysis requiring emergency BAE were excluded. Patients presenting with persistent hemoptysis that was resistant to conservative treatment received BAE. Radiologists measured BA diameters at the ostium, bronchial bifurcation and pulmonary hilum, and also evaluated the degree of vascularization.
RESULTS: MDCT enabled visualization of 102 ostia and 96 traceable BAs. Among the participating patients, 13 had at least one ectopic origin. We obtained a good correlation between BAG and MDCT diameters (r = 0.709, p < 0.001). The diameters of BAs responsible for bleeding and receiving BAE were apparently larger in each measured segment than those that were not (p < 0.05). Moreover, the diameters of arteries receiving BAE remained largely unchanged from the origin to the hilum and through the mediastinum. BAs with low MDCT scores were significantly less likely to required BAE than those with high scores (p = 0.004), and in multiple logistic regression analysis, ostium diameter and bleeding status were independent predictive factors for BAE.
CONCLUSIONS: Evaluation of BAs on MDCT could be useful for identifying the anatomical characteristics of bleeding-related BAs and determining whether BAE is indicated or whether conservative treatment is sufficient.

Entities:  

Mesh:

Year:  2009        PMID: 19864882     DOI: 10.1159/000253882

Source DB:  PubMed          Journal:  Respiration        ISSN: 0025-7931            Impact factor:   3.580


  6 in total

1.  Optimal scanning timing by use of multi-detector row computed tomography during thoracic aortography for depiction of arteries causing hemoptysis.

Authors:  Seiki Hosokawa; Nobuyuki Kawai; Morio Sato; Hiroki Minamiguchi; Hiroki Sanda; Motoki Nakai; Kazuhiro Murotani; Tadayoshi Nishioku; Tetsuo Sonomura
Journal:  Radiol Phys Technol       Date:  2013-12-03

2.  Variations of bronchial artery origin in 600 patients: Systematic analysis with multidetector computed tomography and digital subtraction angiography.

Authors:  Won Seok Choi; Min Uk Kim; Hyo-Cheol Kim; Chang Jin Yoon; Jae Hwan Lee
Journal:  Medicine (Baltimore)       Date:  2021-06-04       Impact factor: 1.817

Review 3.  Predicting and managing the risk of pulmonary haemorrhage in patients with NSCLC treated with bevacizumab: a consensus report from a panel of experts.

Authors:  M Reck; F Barlesi; L Crinò; C I Henschke; D Isla; S Stiebeler; D R Spigel
Journal:  Ann Oncol       Date:  2011-11-04       Impact factor: 32.976

4.  Bronchial artery embolization for management of massive cryptogenic hemoptysis: a case series.

Authors:  Katerina D Samara; Dimitrios Tsetis; Katerina M Antoniou; Charalambos Protopapadakis; George Maltezakis; Nikolaos M Siafakas
Journal:  J Med Case Rep       Date:  2011-02-10

5.  Bronchial artery embolization in life-threatening massive hemoptysis.

Authors:  Hossein Ghanaati; Ali Shakouri Rad; Kavous Firouznia; Amir Hossein Jalali
Journal:  Iran Red Crescent Med J       Date:  2013-12-05       Impact factor: 0.611

6.  Efficacy, safety and usability of bronchial artery embolization using a new anti-reflux microcatheter in the management of haemoptysis.

Authors:  Salvatore Alessio Angileri; Giovanni Maria Rodà; Antonio Arrichiello; Giulia Signorelli; Letizia Di Meglio; Martina Gurgitano; Francesco Di Bartolomeo; Anna Maria Ierardi; Aldo Paolucci; Gianpaolo Carrafiello
Journal:  Acta Biomed       Date:  2020-09-23
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.